Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.34 USD | -0.08% | -1.27% | -19.51% |
02-12 | Craig-Hallum Adjusts Proto Labs Price Target to $38 From $30, Maintains Hold Rating | MT |
02-09 | Transcript : Proto Labs, Inc., Q4 2023 Earnings Call, Feb 09, 2024 |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company does not generate enough profits, which is an alarming weak point.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.45 times its estimated earnings per share for the ongoing year.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.51% | 802M | C | ||
+12.53% | 82.35B | A- | ||
+19.91% | 71.09B | B | ||
+20.26% | 37.73B | B- | ||
+15.36% | 32.01B | A | ||
+9.19% | 27.2B | B- | ||
+4.21% | 26.74B | C+ | ||
+3.90% | 26B | B+ | ||
+13.27% | 25.5B | B+ | ||
+16.95% | 24.76B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRLB Stock
- Ratings Proto Labs, Inc.